Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98151-98200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04766190
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
NARecruiting
260 participants
Started: Feb 10, 2021 · Completed: Aug 31, 2028
5 conditions1 sponsor1 location
NCT04640987
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
PHASE1Recruiting
22 participants
Started: Feb 10, 2021 · Completed: Mar 31, 2029
1 condition2 sponsors1 location
NCT05562804
Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery
N/ARecruiting
200 participants
Started: Feb 10, 2021 · Completed: Feb 10, 2026
2 conditions1 sponsor1 location
NCT04505072
RCT of PR-ESSENCE - a Problem Solving Model for Youth With Challenging Behavior in Special (SiS) Treatment Homes
NARecruiting
70 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04618471
Paresthesia-Free Fast-Acting Subperception (FAST) Study
NAActive, not recruiting
177 participants
Started: Feb 10, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor13 locations
NCT04585269
Bright IDEAS - Young Adults Problem-Solving Skills Training
NAActive, not recruiting
344 participants
Started: Feb 10, 2021 · Completed: Apr 30, 2026
3 conditions5 sponsors3 locations
NCT04142905
Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis
N/AActive, not recruiting
200 participants
Started: Feb 10, 2021 · Completed: Oct 1, 2025
3 conditions1 sponsor1 location
NCT05587842
Early vs Delayed Weightbearing After Surgical Fixation of Unstable Ankle Fractures With Syndesmosis Disruption
NAEnrolling by invitation
150 participants
Started: Feb 10, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT04632433
Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma
PHASE2Active, not recruiting
25 participants
Started: Feb 10, 2021 · Completed: Feb 1, 2026
1 condition1 sponsor7 locations
NCT04319627
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
PHASE3Recruiting
2,700 participants
Started: Feb 10, 2021 · Completed: Apr 30, 2028
3 conditions1 sponsor18 locations
NCT06884631
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
N/ARecruiting
10,000 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2028
1 condition30 sponsors26 locations
NCT04731558
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
PHASE4Recruiting
1,012 participants
Started: Feb 10, 2021 · Completed: Mar 31, 2027
5 conditions3 sponsors7 locations
NCT04505267
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer
PHASE1Recruiting
24 participants
Started: Feb 10, 2021 · Completed: Mar 31, 2026
14 conditions2 sponsors1 location
NCT06255041
Detection of Cancer in Breath Samples by Trained Detection Dogs
N/ARecruiting
1,250 participants
Started: Feb 10, 2021 · Completed: Mar 31, 2024
4 conditions1 sponsor2 locations
NCT04228991
Hypofractionated LocoRegional Radiotherapy in Breast Cancer
PHASE3Active, not recruiting
588 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2030
3 conditions1 sponsor20 locations
NCT05286242
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
N/AActive, not recruiting
400 participants
Started: Feb 10, 2021 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT04760275
Fluoxetine vs CBT in Childhood Anxiety Disorders
PHASE3Active, not recruiting
316 participants
Started: Feb 10, 2021 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT04542733
The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient
NARecruiting
50 participants
Started: Feb 10, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT04349514
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)
N/AActive, not recruiting
300 participants
Started: Feb 10, 2021 · Completed: Oct 31, 2025
1 condition8 sponsors7 locations
NCT07120269
Predictive Markers of the Course of Covid-19 Based on Biomarker Serum Amyloid A (SAA) and Genetic Markers
NAActive, not recruiting
500 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04850287
Improving Health Awareness Using Social Network Interventions
NAActive, not recruiting
2,000,000 participants
Started: Feb 10, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04517851
Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
PHASE2Active, not recruiting
15 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT03616041
Capsule Endoscopy for Severe Hematochezia
N/ARecruiting
23 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT04163614
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
NARecruiting
69 participants
Started: Feb 10, 2021 · Completed: Jul 1, 2026
4 conditions1 sponsor1 location
NCT04721132
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
PHASE2Active, not recruiting
16 participants
Started: Feb 10, 2021 · Completed: Dec 31, 2027
5 conditions1 sponsor2 locations
NCT04576442
Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)
NAActive, not recruiting
452 participants
Started: Feb 9, 2021 · Completed: Sep 30, 2025
1 condition4 sponsors1 location
NCT04750915
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
N/AActive, not recruiting
566,398 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2050
3 conditions1 sponsor1 location
NCT04500041
Casting Vs Bracing for Idiopathic Early-Onset Scoliosis
NAActive, not recruiting
71 participants
Started: Feb 9, 2021 · Completed: Jan 30, 2026
2 conditions3 sponsors26 locations
NCT04594993
INFINITY™ With ADAPTIS™ Technology Study
N/AActive, not recruiting
200 participants
Started: Feb 9, 2021 · Completed: Nov 30, 2035
1 condition1 sponsor13 locations
NCT04462406
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
PHASE2Recruiting
150 participants
Started: Feb 9, 2021 · Completed: Aug 29, 2026
11 conditions2 sponsors482 locations
NCT04063501
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
N/ARecruiting
40 participants
Started: Feb 9, 2021 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT04448301
PC001- A Study to Evaluate the Usability of PointCheck
NARecruiting
100 participants
Started: Feb 9, 2021 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT04567420
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
PHASE2Recruiting
70 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor19 locations
NCT04598230
Partners in Caring for Anxious Youth
PHASE3Active, not recruiting
468 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2026
3 conditions3 sponsors3 locations
NCT04587869
Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men
NARecruiting
370 participants
Started: Feb 9, 2021 · Completed: Jun 1, 2025
2 conditions4 sponsors1 location
NCT05708677
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB
N/AEnrolling by invitation
22 participants
Started: Feb 9, 2021 · Completed: Aug 31, 2036
1 condition1 sponsor2 locations
NCT04753970
Retina is a Marker for Cerebrovascular Heath
PHASE1/PHASE2Recruiting
100 participants
Started: Feb 9, 2021 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT04643327
Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease
PHASE2Recruiting
28 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2025
3 conditions5 sponsors1 location
NCT04657081
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
PHASE1/PHASE2Active, not recruiting
101 participants
Started: Feb 9, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor34 locations
NCT04501081
Natural History of Autosomal Dominant Hearing Loss
N/ARecruiting
1,100 participants
Started: Feb 9, 2021 · Completed: Aug 21, 2029
1 condition1 sponsor1 location
NCT04805814
Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial
NAActive, not recruiting
280 participants
Started: Feb 9, 2021 · Completed: Oct 1, 2034
6 conditions4 sponsors3 locations
NCT07167069
India HIV-CervCa Project
N/AActive, not recruiting
180 participants
Started: Feb 9, 2021 · Completed: May 31, 2026
3 conditions3 sponsors1 location
NCT04696692
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
NAActive, not recruiting
60 participants
Started: Feb 9, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT04789252
Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer
N/ARecruiting
64 participants
Started: Feb 9, 2021 · Completed: Feb 9, 2026
1 condition1 sponsor2 locations
NCT04583774
Developing an EEG Paradigm to Study Prediction Error in Anorexia Nervosa
NAActive, not recruiting
47 participants
Started: Feb 9, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04309695
The Zenflow Spring System Safety and Performance Study (ZEST CAN)
NARecruiting
40 participants
Started: Feb 9, 2021 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT04936776
Pediatric Vaccinations
N/AEnrolling by invitation
1,203 participants
Started: Feb 9, 2021 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT04148417
Clinical Study of the Solo+ Tympanostomy Tube Device
NAActive, not recruiting
27 participants
Started: Feb 9, 2021 · Completed: Sep 30, 2024
2 conditions1 sponsor2 locations
NCT04762030
Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study
PHASE2Recruiting
39 participants
Started: Feb 8, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05053568
Image Supported Lead Placement in CRT
NAActive, not recruiting
130 participants
Started: Feb 8, 2021 · Completed: Oct 31, 2025
1 condition4 sponsors7 locations